Zyrtec® (cetirizine)

DRUG2 trials

Sponsors

Organon and Co

Conditions

Allergies

Phase 4

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

CompletedNCT00779116

Organon and CoAllergies

Start: 2005-09-30End: 2005-10-31Updated: 2022-02-09

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)

CompletedNCT00780403

Organon and CoAllergies

Start: 2005-08-31End: 2005-10-31Updated: 2022-02-09